Correction: MicroRNA signatures of TRAIL resistance in human non-small cell lung cancer (Oncogene, (2008), 27, 27, (3845-3855), 10.1038/onc.2008.6);MicroRNA signatures of TRAIL resistance in human non-small cell lung cancer

Oncogene

Volumn 27, Issue 27, 2008, Pages 3845-3855

  Garofalo, M ^a,b,c   Quintavalle, C ^a,b   Di Leva, G ^c   Zanca, C ^a,b   Romano, G ^a,b   Taccioli, C ^c   Liu, C G ^c   Croce, C M ^c   Condorelli, G ^a,b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b CNR   (Italy)

^c OHIO STATE UNIVERSITY   (United States)

Author keywords

Apoptosis; MicroRNA; Non small cell lung cancer

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1B; MESSENGER RNA; MICRORNA; RNA ANTIBODY; STEM CELL FACTOR; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

3' UNTRANSLATED REGION; APOPTOSIS; ARTICLE; CANCER CELL; CANCER RESISTANCE; CELL STRAIN; CONTROLLED STUDY; GENE EXPRESSION PROFILING; GENETIC TRANSFECTION; GENOME; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENSITIVITY ANALYSIS; SIGNAL TRANSDUCTION;

EID: 42749093490     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/s41388-020-01608-1     Document Type: Erratum

References (39)

1. Blain SW, Scher HI, Cordon-Cardo C, Koff A. (2003). p27 as a target for cancer therapeutics. Cancer Cell 3: 111-115.
2. Brown JM, Attardi LD. (2005). The role of apoptosis in cancer development and treatment response. Nat Rev Cancer 5: 231-237.
3. Calin GA, Croce CM. (2006). MicroRNA signatures in human cancers. Nat Rev Cancer 6: 857-866.
4. Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E et al. (2002). Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 99: 15524-15529.
5. Calin GA, Ferracin M, Cimmino A, Di Leva G, Shimizu M, Wojcik SE et al. (2005). A microRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med 353: 1793-1801.
6. Chen CZ, Li L, Lodish HF, Bartel DP. (2004). MicroRNAs modulate hematopoietic lineage differentiation. Science 303: 83-86.
7. Cheng AM, Byrom MW, Shelton J, Ford LP. (2005). Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis. Nucleic Acids Res 33: 1290-1297.
8. Coqueret O. (2003). New roles for p21 and p27 cell-cycle inhibitors: a function for each cell compartment? Trends Cell Biol 13: 65-70.
9. Corsten MF, Miranda R, Kasmieh R, Krichevsky AM, Weissleder R, Shah K. (2007). MicroRNA-21 knockdown disrupts glioma growth in vivo and displays synergistic cytotoxicity with neural precursor cell delivered S-TRAIL in human gliomas. Cancer Res 67: 8994-9000.
10. kip1 induces cell cycle arrest and loss of cyclin-Cdk activity in human breast cancer cells. Oncogene 14: 2283-2289.
11. Dresios J, Aschrafi A, Owens GC, Vanderklish PW, Edelman GM, Mauro VP. (2005). Cold stress-induced protein Rbm3 binds 60S ribosomal subunits, alters microRNA levels, and enhances global protein synthesis. Proc Natl Acad Sci USA 102: 1865-1870.
12. kip1 mediates its anti-apoptotic activity. Oncogene 18: 4839-4847.
13. Falschlehner C, Emmerich CH, Gerlach B, Walczak H. (2007). TRAIL signalling: decisions between life and death. Int J Biochem Cell Biol 39: 1462-1475.
14. Felli N, Fontana L, Pelosi E, Botta R, Bonci D, Facchiano F et al. (2005). MicroRNAs 221 and 222 inhibit normal erythropoiesis and erythroleukemic cell growth via kit receptor down-modulation. Proc Natl Acad Sci USA 102: 18081-18086.
15. Fulda S, Meyer E, Debatin KM. (2000). Metabolic inhibitors sensitize for CD95 (APO-1/Fas)-induced apoptosis by down-regulating Fas-associated death domain-like interleukin 1-converting enzyme inhibitory protein expression. Cancer Res 60: 3947-3956.
16. kip1. J Biol Chem 282: 23716-23724.
17. Garofalo M, Romano G, Quintavalle C, Romano MF, Chiurazzi F, Zanca C et al. (2007). Selective inhibition of PED protein expression sensitizes B-cell chronic lymphocytic leukaemia cells to TRAIL-induced apoptosis. Int J Cancer 120: 1215-1222.
18. Ghobrial IM, Witzig TE, Adjei AA. (2005). Targeting apoptosis pathways in cancer therapy. CA Cancer J Clin 55: 178-194.
19. He H, Jazdzewski K, Li W, Liyanarachchi S, Nagy R, Volinia S et al. (2005). The role of microRNA genes in papillary thyroid carcinoma. Proc Natl Acad Sci USA 102: 19075-19080.
20. Johnson SM, Grosshans H, Shingara J, Byrom M, Jarvis R, Cheng A et al. (2005). RAS is regulated by the let-7 microRNA family. Cell 120: 635-647.
21. Katayose Y, Kim M, Rakkar AN, Li Z, Cowan KH, Seth P. (1997). Promoting apoptosis: a novel activity associated with the cyclin-dependent kinase inhibitor p27. Cancer Res 57: 5441-5445.
22. Koschny R, Walczak H, Ganten TM. (2007). The promise of TRAIL-potential and risks of a novel anticancer therapy. J Mol Med 85: 923-935.
23. kip1) tumor suppressor by miR-221 and miR-222 promotes cancer cell proliferation. EMBO J 26: 3699-3708.
24. Liu CG, Calin GA, Meloon B, Gamliel N, Sevignani C, Ferracin M et al. (2004). An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues. Proc Natl Acad Sci USA 101: 9740-9744.
25. Mott JL, Kobayashi S, Bronk SF, Gores GJ. (2007). mir-29 regulates Mcl-1 protein expression and apoptosis. Oncogene 26: 6133-6140.
26. Ovcharenko D, Kelnar K, Johnson C, Leng N, Brown D. (2007). Genome-scale microRNA and small interfering RNA screens identify small RNA modulators of TRAIL-induced apoptosis pathway. Cancer Res 67: 10782-10788.
27. Poliseno L, Tuccoli A, Mariani L, Evangelista M, Citti L, Woods K et al. (2006). MicroRNAs modulate the angiogenic properties of HUVECs. Blood 108: 3068-3071.
28. Poy MN, Eliasson L, Krutzfeldt J, Kuwajima S, Ma X, Macdonald PE et al. (2004). A pancreatic islet-specific microRNA regulates insulin secretion. Nature 432: 226-230.
29. Schaefer U, Voloshanenko O, Willen D, Walczak H. (2007). TRAIL: a multifunctional cytokine. Front Biosci 12: 3813-3824.
30. Sempere LF, Freemantle S, Pitha-Rowe I, Moss E, Dmitrovsky E, Ambros V. (2004). Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation. Genome Biol 5: R13.
31. 1-phase progression. Genes Dev 13: 1501-1512.
32. Smirnova L, Grafe A, Seiler A, Schumacher S, Nitsch R, Wulczyn FG. (2005). Regulation of miRNA expression during neural cell specification. Eur J Neurosci 21: 1469-1477.
33. kip1 on resistance of tumor cells to anticancer agents. Nat Med 2: 1204-1210.
34. Tamborini E, Bonadiman L, Negri T, Greco A, Staurengo S, Bidoli P et al. (2004). Detection of overexpressed and phosphorylated wild-type kit receptor in surgical specimens of small cell lung cancer. Clin Cancer Res 10: 8214-8219.
35. Walczak H, Krammer PH. (2000). The CD95 (APO-1/Fas) and the TRAIL (APO-2L)apoptosis systems. Exp Cell Res 256: 58-66.
36. Walczak H, Miller RE, Ariail K, Gliniak B, Griffith TS, Kubin M et al. (1999). Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. Nat Med 5: 157-163.
37. kip1 expression. Blood 101: 1439-1445.
38. Xu P, Guo M, Hay BA. (2004). MicroRNAs and the regulation of cell death. Trends Genet 20: 617-624.
39. Xu P, Vernooy SY, Guo M, Hay BA. (2003). The Drosophila microRNA Mir-14 suppresses cell death and is required for normal fat metabolism. Curr Biol 13: 790-795.